Corbus Pharmaceuticals Holdings, Inc. (CRBP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 143.57M | 166.95M | 107.57M | 122.83M | 137.36M | 152.98M | 160.89M | 148.31M | 121.7M | 23.55M | 31.21M | 38.27M |
| Cash & Short-Term Investments | 138.6M | 163.94M | 103.98M | 116.59M | 132.79M | 149.06M | 159.36M | 147.31M | 120.1M | 20.91M | 28.73M | 36.57M |
| Cash Only | 26.05M | 28.49M | 26.98M | 20.04M | 18.9M | 17.2M | 19.42M | 23.97M | 14.1M | 13.72M | 11.25M | 8.35M |
| Short-Term Investments | 112.56M | 134.78M | 77M | 96.55M | 113.89M | 131.86M | 139.94M | 123.34M | 106M | 7.18M | 17.48M | 28.22M |
| Accounts Receivable | 0 | 1.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.08M | 1.51M | 3.59M | 1.78M | 4.57M | 3.91M | 285K | 0 | 1.59M | 192K | 192.47K | 1.71M |
| Total Non-Current Assets | 914K | 1.24M | 1.94M | 2.26M | 2.57M | 2.9M | 3.28M | 3.67M | 4.05M | 4.73M | 5.08M | 5.45M |
| Property, Plant & Equipment | 914K | 1.24M | 1.56M | 1.88M | 2.19M | 2.52M | 2.9M | 3.28M | 3.66M | 4.04M | 4.4M | 4.76M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 385K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 385K | 385K | 385K | 385K | 385K | 0 | 384.95K | 690K | 678.7K | 689.37K |
| Total Assets | 144.48M | 168.19M | 109.51M | 125.08M | 139.93M | 155.88M | 164.17M | 151.98M | 125.74M | 28.27M | 36.28M | 43.72M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 3.25% | 7.9% | -33.29% | -17.7% | 11.28% | 451.35% | 352.47% | 247.59% | 143.48% | -57.37% | -50.86% | -46.72% |
| Total Current Liabilities | 18.14M | 20.69M | 17.06M | 13.33M | 11.62M | 11.82M | 11.63M | 23.98M | 25.92M | 31.89M | 31.54M | 16.39M |
| Accounts Payable | 435K | 2.21M | 2.74M | 3.99M | 4.07M | 4.79M | 2.89M | 1.15M | 2.08M | 3.18M | 4.71M | 1.51M |
| Days Payables Outstanding | 2.43K | - | - | 3.67K | 25.47 | 2.42K | - | 735.69 | - | 2.45K | - | - |
| Short-Term Debt | 1.21M | 0 | 0 | 0 | 0 | 0 | 0 | 10.82M | 12.95M | 16.21M | 17.85M | 7.07M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15.27M | 16.84M | 2.41M | 0 | 999K | 2.28M | 0 | 0 | 811.13K | 39K | 36.87K | 1.61M |
| Current Ratio | 7.92x | 8.07x | 6.31x | 9.21x | 11.82x | 12.94x | 13.84x | 6.18x | 4.69x | 0.74x | 0.99x | 2.34x |
| Quick Ratio | 7.92x | 8.07x | 6.31x | 9.21x | 11.82x | 12.94x | 13.84x | 6.18x | 4.69x | 0.74x | 0.99x | 2.34x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 307K | 761K | 1.21M | 1.63M | 2.05M | 2.46M | 2.86M | 3.28M | 4.43M | 17.82M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.32M |
| Capital Lease Obligations | 0 | 0 | 307K | 761K | 1.21M | 1.63M | 2.05M | 2.46M | 2.86M | 3.24M | 3.61M | 3.98M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44K | 819.41K | 2.52M |
| Total Liabilities | 18.14M | 20.69M | 17.37M | 14.09M | 12.82M | 13.45M | 13.67M | 26.44M | 28.78M | 35.18M | 35.97M | 34.2M |
| Total Debt | 1.21M | 1.63M | 2.05M | 2.46M | 2.85M | 3.24M | 3.61M | 14.8M | 17.29M | 20.89M | 22.86M | 23.72M |
| Net Debt | -24.84M | -26.86M | -24.93M | -17.59M | -16.05M | -13.96M | -15.81M | -9.18M | 3.18M | 7.16M | 11.61M | 15.37M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.12x | 0.18x | - | 73.49x | 2.49x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | -35.18x | -14.33x | -34.23x | -10.35x | -11.89x | -7.71x |
| Total Equity | 126.34M | 147.5M | 92.15M | 110.99M | 127.11M | 142.43M | 150.5M | 125.54M | 96.97M | -6.91M | 311.02K | 9.52M |
| Equity Growth % | -0.6% | 3.56% | -38.77% | -11.59% | 31.08% | 2162.68% | 48289.15% | 1218.65% | 489.14% | -120.93% | -99.26% | -80.75% |
| Book Value per Share | 9.49 | 11.08 | 7.49 | 9.07 | 10.42 | 11.69 | 12.53 | 44.64 | 34.48 | -1.56 | 0.07 | 2.23 |
| Total Shareholders' Equity | 126.34M | 147.5M | 92.15M | 110.99M | 127.11M | 142.43M | 150.5M | 125.54M | 96.97M | -6.91M | 311.02K | 9.52M |
| Common Stock | 2K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 1.05K | 0 | 442 | 442 |
| Retained Earnings | -578.4M | -555.43M | -534.88M | -511.53M | -493.87M | -476.89M | -467.36M | -453.58M | -443.58M | -436.68M | -428.66M | -418.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -161K | -53K | -3K | -39K | -23K | 35K | 207K | -388K | -328.5K | -1K | -8.04K | -23.79K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |